UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | P | R | S | T | V | W | Z
Number of items: 45.

A

Arkenau, H-T; Saggese, M; Lemech, C; (2012) Advanced gastric cancer: Is there enough evidence to call second-line therapy standard? WORLD JOURNAL OF GASTROENTEROLOGY , 18 (44) pp. 6376-6378. 10.3748/wjg.v18.i44.6376. Gold open access

Arkenau, H-T; Saggese, M; Lemech, C; (2012) DABRAFENIB MESYLATE Serine/Threonine-Protein Kinase B-raf Inhibitor, Oncolytic. DRUGS OF THE FUTURE , 37 (7) pp. 469-474. 10.1358/dof.2012.37.7.1820872.

B

Butt, MA; Pye, H; Haidry, RJ; Oukrif, D; Rashid, M; Banks, MR; Deonarain, MP; ... Lovat, LB; + view all (2012) ABERRANTLY GLYCOSYLATED MUC1 AS A POTENTIAL THERAPEUTIC TARGET FOR BARRETT'S WITH HIGH GRADE DYSPLASIA AND PRIMARY AND METASTATIC OESOPHAGEAL ADENOCARCINOMA. In: (pp. A301-A301). B M J PUBLISHING GROUP

C

Cain, RJ; Vanhaesebroeck, B; Ridley, AJ; (2012) Different PI 3-kinase inhibitors have distinct effects on endothelial permeability and leukocyte transmigration. Int J Biochem Cell Biol , 44 (11) pp. 1929-1936. 10.1016/j.biocel.2012.07.009.

Cervantes, A; Markman, B; Siena, S; Pericay, C; Aprile, G; Bridgewater, J; Cubillo, A; ... Tabernero, J; + view all (2012) Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2nd line metastatic colorectal cancer (mCRC). CANCER RESEARCH , 72 10.1158/1538-7445.AM2012-LB-220.

Chen, P; Tu, X; Akdemir, F; Chew, SK; Rothenfluh, A; Abrams, JM; (2012) Effectors of alcohol-induced cell killing in Drosophila. Cell Death Differ , 19 (10) pp. 1655-1663. 10.1038/cdd.2012.47.

Corrie, P; Caplin, M; Reed, N; Qain, W; Lao-Sirieix, S-H; Hardy, R; Armstrong, G; ... Meyer, T; + view all (2012) Treatment of advanced neuroendocrine tumors: Results of the UKINETS and NCRI randomized phase II NET01 trial. In: (Proceedings) ASCO Annual Meeting. (pp. 4121-).

Corrie, P; Caplin, M; Reed, N; Qian, W; Lao-Sirieix, S-H; Hardy, R; Armstrong, G; ... Meyer, T; + view all (2012) Treatment of advanced neuroendocrine tumors: Results of the UKINETS and NCRI randomized phase II NET01 trial. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

D

Dubois, E; Jacoby, M; Blockmans, M; Pernot, E; Schiffmann, SN; Foukas, LC; Henquin, J-C; ... Schurmans, S; + view all (2012) Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse. CELLULAR SIGNALLING , 24 (11) pp. 1971-1980. 10.1016/j.cellsig.2012.06.012.

E

Enting, D; Ang, JE; O'Hanlon-Brown, C; Kristeleit, RS; Uttenreuther-Fischer, M; Pemberton, K; Pelling, K; ... Spicer, J; + view all (2012) A PHASE I STUDY OF DAILY AFATINIB, AN IRREVERSIBLE ERBB FAMILY BLOCKER, COMBINED WITH WEEKLY PACLITAXEL AND 2-WEEKLY BEVACIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMOURS. Annals of Oncology , 23 (Suppl 9) 10.1093/annonc/mds395.

F

Flaherty, K; Metric Study Group, ; (2012) Improved survival with MEK inhibition in BRAF-mutated melanoma. New England Journal of Medicine 10.1056/NEJMoa1203421.

Forster, M; Mendes, R; Fedele, S; (2012) Synthetic Lethality and PARP-Inhibitors in Oral and Head & Neck Cancer. CURRENT PHARMACEUTICAL DESIGN , 18 (34) pp. 5431-5441. 10.2174/138161212803307608.

G

Goodwin, R; Giaccone, G; Calvert, H; Lobbezoo, M; Eisenhauer, EA; (2012) Targeted agents: How to select the winners in preclinical and early clinical studies? EUROPEAN JOURNAL OF CANCER , 48 (2) pp. 170-178. 10.1016/j.ejca.2011.09.024.

H

Howie, AJ; (2012) Diagnosis of amyloid using Congo red. In: Picken, MM and Dogan, A and Herrera, G, (eds.) Amyloid and related disorders: surgical pathology and clinical correlations. (pp. 167-174). Springer: New York, USA.

Howie, AJ; Owen-Casey, MP; (2012) 'Apple-green birefringence' of amyloid stained by Congo red. KIDNEY INTERNATIONAL , 82 (1) p. 114. 10.1038/ki.2012.89.

J

Jayakody, SA; (2012) Investigating genetic factors underlying hypopituitarism and septo-optic dysplasia in humans. Doctoral thesis , UCL (University College London).

K

Khan, MS; Thirlwell, C; Toumpanakis, C; Caplin, M; Meyer, T; (2012) An Acute Shower of Circulating Tumour Cells Following Transarterial Embolisation (TAE). In: (Proceedings) Digestive Disease Week (DDW). (pp. S763-S763). W B SAUNDERS CO-ELSEVIER INC

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Hartley, JA; Caplin, ME; Meyer, T; (2012) Circulating tumor cells as prognostic and predictive markers in neuroendocrine tumors. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

L

Lee, M; Satam, V; Babu, B; Gregory, M; Bowerman, M; Savagian, M; Lee, M; ... Hartley, JA; + view all (2012) Complete analysis on the two base pair sequence recognition by Hx (p-anisylbenzimidazole)center dot pyrrole and Hx center dot imidazole pairings. In: (Proceedings) 244th National Fall Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Lee, M; Satam, V; Babu, B; Porte, A; Savagian, M; Lee, MD; Liu, Y; ... Hartley, JA; + view all (2012) Synthesis and DNA binding properties of 1-(3-aminopropyl)imidazole-containing triamide f-Im*PyIm: a novel diamino polyamide designed to target 5 '-ACGCGT-3 '. In: (Proceedings) 244th National Fall Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Lucas, G; Win, N; Calvert, A; Green, A; Griffin, E; Bendukidze, N; Hopkins, M; ... Massey, E; + view all (2012) Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. VOX SANGUINIS , 103 (1) pp. 10-17. 10.1111/j.1423-0410.2011.01570.x.

M

Maharaj, L; Popat, R; Gribben, JG; Joel, S; (2012) IL-6, IL-8 and VEGF Neutralisation Restores Drug Sensitivity to Conventional and Novel Treatment Combinations in a Multiple Myeloma Bone Marrow Micro-Environment Model. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Marquardt, J; Begent, RHJ; Chester, K; Huston, JS; Bradbury, A; Scott, JK; Thorpe, PE; ... Weiner, LM; + view all (2012) IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA. MAbs , 4 (6) pp. 648-652. 10.4161/mabs.22221.

Meyer, T; Caplin, M; Reed, N; Qian, W; Lao-Sirieix, S; Armstrong, G; Valle, J; ... Corrie, P; + view all (2012) TREATMENT OF ADVANCED NEUROENDOCRINE TUMOURS: FINAL RESULTS OF THE UKINETS AND NCRI RANDOMISED PHASE 2 NET01 TRIAL. In: (Proceedings) 37th Congress of the European-Society-for-Medical-Oncology (ESMO). (pp. pp. 378-379). OXFORD UNIV PRESS

Meyer, T; Fox, R; Bird, D; Watkinson, A; Hacking, N; Stocken, D; Johnson, P; (2012) TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC). In: (Proceedings) ASCO Annual Meeting. (pp. 4150-).

Miller, J; Doss, M; McQuillen, R; Shaller, CC; Tolner, B; Yu, JQ; Chester, K; (2012) Impact of expression system on the function of the C6.5 diabody PET radiotracer. Tumor Biology pp. 1-11.

Miranda, E; Maya Pineda, H; Öberg, D; Cherubini, G; Garate, Z; Lemoine, NR; Halldén, G; (2012) Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region. PLoS ONE , 7 (10) , Article e46617. 10.1371/journal.pone.0046617. Green open access
file

N

Nagano, K; Akpan, A; Warnasuriya, G; Corless, S; Totty, N; Yang, A; Stein, R; ... Naaby-Hansen, S; + view all (2012) Functional Proteomic Analysis of Long-term Growth Factor Stimulation and Receptor Tyrosine Kinase Coactivation in Swiss 3T3 Fibroblasts. Molecular & Cellular Proteomics , 11 (12) pp. 1690-1708. 10.1074/mcp.M112.019778. Green open access
file

P

Palmer, D; Loembe, AB; Studeny, M; Hocke, J; Meyer, T; (2012) PHASE I STUDY OF NINTEDANIB (BIBF 1120) IN EUROPEAN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA. In: (Proceedings) 37th Congress of the European-Society-for-Medical-Oncology (ESMO). (pp. p. 245). OXFORD UNIV PRESS

Pericleous, M; Lumgair, H; Reiner, J; Marelli, L; Caplin, M; Meyer, T; Toumpanakis, C; (2012) Bronchial neuroendocrine tumors: A retrospective review of management and outcomes in 116 patients. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Pericleous, M; Toumpanakis, C; Lumgair, H; Reiner, J; Marelli, L; Meyer, T; Caplin, M; (2012) Diagnostic Features and Management Outcomes in Bronchopulmonary Neuroendocrine Tumors: A Clinical Study of 116 Patients. In: (Proceedings) 9th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. (pp. p. 54). KARGER

Ploquin, A; Olmos, D; Lacombe, D; A'Hern, R; Duhamel, A; Twelves, C; Marsoni, S; ... Penel, N; + view all (2012) Prediction of early death among patients enrolled in phase i trials: Development and validation of a new model based on platelet count and albumin. British Journal of Cancer , 107 (7) pp. 1025-1030. 10.1038/bjc.2012.371.

R

Raja, FA; Hook, JM; Ledermann, JA; (2012) Biomarkers in the development of anti-angiogenic therapies for ovarian cancer. CANCER TREATMENT REVIEWS , 38 (6) pp. 662-672. 10.1016/j.ctrv.2011.11.009.

S

Satam, V; Babu, B; Chavda, S; Savagian, M; Sjoholm, R; Tzou, S; Ramos, J; ... Lee, M; + view all (2012) Novel diamino imidazole and pyrrole-containing polyamides: Synthesis and DNA binding studies of mono- and diamino-phenyl-ImPy*Im polyamides designed to target 5 '-ACGCGT-3 ' (vol 20, pg 693, 2012). BIOORGANIC & MEDICINAL CHEMISTRY , 20 (15) p. 4881. 10.1016/j.bmc.2012.06.037.

Slater, S; Witteveen, P; Plummer, R; Kristeleit, R; Evans, T; Reyderman, L; de las Heras, B; ... Schellens, J; + view all (2012) 599 Effect of Food On Relative Bioavailability of E7820 in Cancer Patients. European Journal of Cancer , 48 (S6) p. 184. 10.1016/S0959-8049(12)72396-1.

T

Thirlwell, C; Feber, A; Lechner, M; Teschendorff, AE; Beck, S; (2012) Comments on: Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed paraffin-embedded paired tumor and normal tissue. BMC Res Notes , 5 631-. 10.1186/1756-0500-5-631. Gold open access

Thirlwell, C; Sasmaz, S; Dibra, H; Feber, A; Butcher, L; Meyer, T; Davidson, B; ... Beck, S; + view all (2012) The First Neuroendocrine Tumor Methylome Using Methylation-Specific Immunoprecipitation Followed by Second Generation Sequencing - MeDIP-seq. In: (Proceedings) 9th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. (pp. p. 14). KARGER

Toumpanakis, C; Baneke, A; Pericleous, M; Meyer, T; Caplin, M; (2012) Goblet Cell Appendiceal Neuroendocrine Tumors: Diagnosis, Recurrence Rates, Treatment and Survival. A Series of 37 Patients. In: (Proceedings) 9th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. (pp. p. 64). KARGER

Toumpanakis, C; Baneke, A; Pericleous, M; Meyer, T; Caplin, ME; (2012) Diagnostic and therapeutic outcomes in goblet cell appendiceal neuroendocrine tumors. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Treins, C; Alliouachene, S; Hassouna, R; Xie, Y; Birnbaum, MJ; Pende, M; (2012) The combined deletion of S6K1 and Akt2 deteriorates glycemic control in a high-fat diet. Mol Cell Biol , 32 (19) pp. 4001-4011. 10.1128/MCB.00514-12.

Tsochatzis, EA; Meyer, T; Burroughs, AK; (2012) Hepatocellular carcinoma. N.Engl.J.Med. , 366 (1) pp. 92-93. 10.1056/NEJMc1112501#SA2.

V

Vincenzi, B; Santini, D; Schiavon, G; Frezza, AM; Dileo, P; Silletta, M; Bertoldo, F; ... Tonini, G; + view all (2012) Bone metastases in soft tissue sarcoma patients: A survey of natural, prognostic value, and treatment. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

W

Weatherstone, K; Meyer, T; (2012) Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Targeted Oncology , 7 (3) pp. 161-168. 10.1007/s11523-012-0224-y.

Whelan, J; Hook, J; Bielack, SS; Marina, N; Smeland, S; Jovic, G; Krailo, MD; ... Bernstein, ML; + view all (2012) EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma. Presented at: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL.

Z

Zhang, T; Penicud, K; Bruhn, C; Loizou, JI; Kanu, N; Wang, Z-Q; Behrens, A; (2012) Competition between NBS1 and ATMIN controls ATM signaling pathway choice. Cell Rep , 2 (6) pp. 1498-1504. 10.1016/j.celrep.2012.11.002.

This list was generated on Sun May 20 01:52:23 2018 BST.